A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis

MLA

Stéphanie Nadeau, et al. “A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis.” Stem Cells Translational Medicine, vol. 6, Feb. 2017, pp. 1132–40. EBSCOhost, https://doi.org/10.1002/sctm.16-0221.

APA

Stéphanie Nadeau, Ozge Kizilay Mancini, Francis Rodier, Dominique Shum-Tim, Maximilien Lora, & Ines Colmegna. (2017). A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis. Stem Cells Translational Medicine, 6, 1132–1140. https://doi.org/10.1002/sctm.16-0221

Chicago

Stéphanie Nadeau, Ozge Kizilay Mancini, Francis Rodier, Dominique Shum-Tim, Maximilien Lora, and Ines Colmegna. 2017. “A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis.” Stem Cells Translational Medicine 6 (February): 1132–40. doi:10.1002/sctm.16-0221.